.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Dow
McKinsey
Federal Trade Commission
Express Scripts
Deloitte
Harvard Business School
AstraZeneca
Chinese Patent Office

Generated: November 20, 2017

DrugPatentWatch Database Preview

REMSED Drug Profile

« Back to Dashboard

What is the patent landscape for Remsed, and when can generic versions of Remsed launch?

Remsed is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in REMSED is promethazine hydrochloride. There are twelve drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.

Medical Subject Heading (MeSH) Categories for REMSED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
REMSED
promethazine hydrochloride
TABLET;ORAL083176-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
REMSED
promethazine hydrochloride
TABLET;ORAL083176-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Healthtrust
Citi
Harvard Business School
Daiichi Sankyo
Chubb
Farmers Insurance
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot